Associations between high-density lipoprotein cholesterol and interstitial lung abnormalities in the Korean national lung cancer screening programme
European Respiratory Journal · 2026
DOI: 10.1183/13993003.01878-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Hyungjin Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea khj.snuh@gmail.com. Hauptthemen laut MEDLINE: Cholesterol, HDL, Lung Neoplasms, Lung Diseases, Interstitial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: College of Medicine, Seoul National University, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
High-density lipoprotein (HDL) cholesterol exerts anti-inflammatory, antioxidative and endothelial-protective effects, yet its role in interstitial lung abnormalities (ILA) remains unclear.
Methods
We analysed baseline screening from heavy smokers who participated in the Korean national lung cancer screening programme (2019–2021). HDL cholesterol was measured at two pre-screening time points (remote and immediate) and categorised as normal or low. Participants were also classified into four HDL cholesterol trajectories: normal-to-normal, low-to-normal, normal-to-low and low-to-low. We used logistic regression to estimate odds ratios for ILA, adjusting for demographic characteristics, body mass index, lifestyle factors, comorbidities, income status, lipid profiles and statin use.
Results
Among 159 729 participants (mean age 61.7 years, 98.2% men), ILA were detected in 2.9%, with higher prevalence in those with low HDL cholesterol at immediate pre-screening compared with normal HDL cholesterol (3.5% versus 2.7%). There was a higher proportion of obesity (6.1% versus 3.5%) and more frequent statin use (40.0% versus 34.4%) among participants with low HDL cholesterol than among those with normal HDL cholesterol. ILA prevalence increased from the normal-to-normal HDL cholesterol group (2.6%) across the low-to-normal (3.1%), normal-to-low (3.5%) and low-to-low (3.6%) groups. Low HDL at immediate pre-screening was associated with a 28% higher risk of ILA (95% CI 1.19–1.38; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea khj.snuh@gmail.com.
- Zarathu Co., Ltd, Seoul, Korea.
- Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea.
- Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
- Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital, Vancouver, BC, Canada.
ORCID-Profile: Anna J Podolanczuk
Förderung
- College of Medicine, Seoul National University
- National Research Foundation of Korea
Zitieren
APA
Kim, H., Jo, E., Kim, J., Yoon, S. H., Podolanczuk, A. J., & Ryerson, C. J. (2026). Associations between high-density lipoprotein cholesterol and interstitial lung abnormalities in the Korean national lung cancer screening programme. European Respiratory Journal. https://doi.org/10.1183/13993003.01878-2025
Vancouver
Kim H, Jo E, Kim J, Yoon SH, Podolanczuk AJ, Ryerson CJ. Associations between high-density lipoprotein cholesterol and interstitial lung abnormalities in the Korean national lung cancer screening programme. European Respiratory Journal. 2026. doi:10.1183/13993003.01878-2025
BibTeX
@article{Kim2026,
author = {Kim, Hyungjin and Jo, Eunseo and Kim, Jinseob and Yoon, Soon Ho and Podolanczuk, Anna J and Ryerson, Christopher J},
title = {Associations between high-density lipoprotein cholesterol and interstitial lung abnormalities in the Korean national lung cancer screening programme},
journal = {European Respiratory Journal},
year = {2026},
doi = {10.1183/13993003.01878-2025}
}
EUVIMED